Clinical trials: TQT Study, open to volunteers
Healthy Participants
A Study to Evaluate the Effects of Therapeutic and Supratherapeutic Doses of KRP-S124 Compared to Placebo With Moxifloxacin on QTc Interval in Healthy Participants
This study is being done to see how KRP-S124 affects the electrical activity of the heart (known as the QTc interval [QT interval corrected for heart rate]) in healthy volunteers.
- Trial name
- NCT07919314
- Testing
- KRP-S124 Low Dose, Moxifloxacin, KRP-S124 Medium Dose
- Where
- Canada
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Kyorin Pharmaceutical Co.,Ltd